ReviewFrontiers in oncology2024

Efficacy and safety of PD-1 inhibitors plus anti-angiogenesis tyrosine kinase inhibitors with or without transarterial chemo(embolization) for unresectable hepatocellular carcinoma: a meta-analysis.

Yue Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.